| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | Director
2 companies
Hawryluk P. Kent is a President &CEO at MBX Biosciences, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $19.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | MBX Mbx Biosciences, Inc. | President &CEO | Buy | 18,500 | $28.41 | $525,662.70 | +4.0% | - | - | |
| Oct 20, 2025 | MBX Mbx Biosciences, Inc. | President &CEO | Buy | 20,000 | $13.64 | $272,790.00 | +4.5% | +203.2% | - | |
| Feb 4, 2025 | MBX Mbx Biosciences, Inc. | President &CEO | Buy | 50,000 | $10.69 | $534,500.00 | +12.6% | +10.4% | +251.1% | |
| Mar 10, 2017 | MTVA Metavia Inc. | Director | Buy | 25,000 | $9.47 | $236,750.00 | +43.9% | - | - | |
| Aug 10, 2016 | MTVA Metavia Inc. | Director | Buy | 25,000 | $10.00 | $250,000.00 | +78.4% | - | - |